Spectre Bio Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Grant

  • Investors
  • 5

Spectre Bio General Information

Description

Developer of a bacterial-like particle platform designed to prevent and broadly protect against infectious diseases by enabling programmable immune activation and antigen presentation. The company's platform offers bacterial-like particles (BLiPs), which are modular, genome-free biological chassis created by inactivating native genomes while preserving essential cellular machinery and repurposed as prophylactic vaccines and innate immune trainers presenting conserved surface antigens in their native context and supporting respiratory tract delivery and local immune priming, enabling healthcare systems and vaccine developers, safer and more predictable prevention of bacterial infections and improved protection against diverse pathogens.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • Bioescalator, Innovation Building
  • Old Road Campus, Roosevelt Drive
  • Oxford OX3 7FZ
  • England, United Kingdom
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • Bioescalator, Innovation Building
  • Old Road Campus, Roosevelt Drive
  • Oxford OX3 7FZ
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Spectre Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 01-May-2026 Completed Startup
4. Accelerator/Incubator 05-Dec-2025 Completed Startup
3. Grant 01-Oct-2025 Completed Startup
2. Accelerator/Incubator 01-Mar-2019 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Spectre Bio’s complete valuation and funding history, request access »

Spectre Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Spectre Bio Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
BARDA Government
BioEscalator Accelerator/Incubator
Innovate UK Government
IMAGINE IF! Accelerator/Incubator
Science Creates Accelerator/Incubator
To view Spectre Bio’s complete investors history, request access »

Spectre Bio FAQs

  • When was Spectre Bio founded?

    Spectre Bio was founded in 2025.

  • Where is Spectre Bio headquartered?

    Spectre Bio is headquartered in Oxford, United Kingdom.

  • What is the size of Spectre Bio?

    Spectre Bio has 2 total employees.

  • What industry is Spectre Bio in?

    Spectre Bio’s primary industry is Biotechnology.

  • Is Spectre Bio a private or public company?

    Spectre Bio is a Private company.

  • What is Spectre Bio’s current revenue?

    The current revenue for Spectre Bio is .

  • Who are Spectre Bio’s investors?

    BARDA, BioEscalator, Innovate UK, IMAGINE IF!, and Science Creates have invested in Spectre Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process